This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (33)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Is There an Association?

John Varga, MD; Sergio A. Jimenez, MD

Arch Dermatol. 1990;126(9):1220-1222.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Augmentation mammoplasty has become a widely employed cosmetic procedure. In the United States an estimated 2 million women have received breast implants.¹ Most of the implants contain silicone gel as the filling material. The gel used in the implant is produced from silica, reduced to form silicone, which is reacted with methylchloride and polymerized to form stable polydimethylsiloxane. Silicone has been extensively employed because of its ideal physical properties and the general perception based on published evidence suggesting that medical-grade silicone polymer is chemically and biologically inert.^2-6 The enormous popularity of silicone mammoplasty, and its rapidly increasing use, render it timely to consider the possible long-term adverse effects of silicone.

Over the past two decades, a variety of complications associated with silicone mammary prostheses, including local infection, pain, and contracture of the fibrous capsule that forms around the implant, have been recognized.⁷ A disturbingly frequent observation is . . . [Full Text PDF of this Article]

Author Affiliations
Department of Medicine Jefferson Medical College Thomas Jefferson University Jefferson Alumni Hall, Room M-26 1020 Locust St Philadelphia, PA 19107

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?